Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Cisplatinum and vinorelbine studied in phase II trial
October 13th, 2005
Researchers conducted a clinical phase II study of cisplatinum and vinorelbine (PVn) in advanced breast carcinoma (ABC). According to recent research published in the American Journal of Clinical Oncology - Cancer Clinical Trials, "The effectiveness of PVn as a salvage regimen in patients with metastatic breast cancer was reported in previous studies. This report is a pilot study assessing the antitumor efficacy and safety of this regimen as first line therapy for advanced breast cancer patients. Thirty-five patients were enrolled: 22 with metastatic breast carcinoma and 13 with locally ABC (stage III)." "A total of 4 cycles of PVn were...
Source: Women's Health Weekly (2005-10-13)
|
